Medicare and Chevron in the Supreme Court’s New Term
With two Medicare cases, the U.S. Supreme Court may change an important rule on deference to agency decisions.
Taking Hearing Aids Over the Counter
FDA proposes a new rule to permit the purchase of hearing aids without a prescription.
Featured Regulatory Series of 2021
The Regulatory Review highlights its series published over the past year.
Top Staff Essays of 2021
The Regulatory Review highlights the top regulatory stories written by our staff in 2021.
Top Contributor Essays of 2021
The Regulatory Review highlights the top essays written by our contributors in 2021.
Can Netflix Win on Neutrality?
The growing popularity of online video streaming forces the issue of network usage fees.
States Regain Regulatory Power Over Predatory Loan Servicers
The Education Department’s new interpretation of federal law empowers states to protect student loan borrowers.
Law Reforms Promote Nurse-Managed Care
Amid rising insured rates, physician shortages, and COVID-19, nurse-led care seeks to address health inequities.
Replacing the World’s Most Important Number
Replacing the primary international interest rate poses risks, but policymakers are ready for the challenge.
The Biden Executive Order on Restructuring Competition
Antitrust experts from the University of Pennsylvania reflect on the possible consequences of the recent Biden executive order on competition.
Formaldehyde Lurks in Hair Products Despite FDA Warning
FDA warns consumers to protect themselves from a known carcinogen in hair smoothing products.
Reversing a Midnight Expansion of the Death Penalty
The Biden Administration is expected to withdraw last-minute Trump Administration death penalty regulation.